Serum Institute of India says ‘will resume Covid vaccine trials’ after drug controller’s nod


Team Udayavani, Sep 13, 2020, 9:56 AM IST

New Delhi: Serum Institute of India will resume clinical trials of AstraZeneca’s COVID-19 vaccine candidate after getting the permission from the Drugs Controller General of India (DCGI), the Pune-based vaccine maker said on Saturday.

Pharma giant AstraZeneca on Saturday said that clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that the trials were safe.

“Once DCGI will give us the permission to restart the trials in India, we will resume the trials,” Serum Institute of India (SII) said in a statement.

In a tweet, SII CEO Adar Poonawalla said: “As I’d mentioned earlier, we should not jump to conclusions until the trials are fully concluded. The recent chain of events is a clear example why we should not bias the process and should respect the process till the end. Good news, @UniofOxford.”

The human trials resumed days after a pause had been announced in the trials after an adverse reaction in one of the participants.

Following the suspension, the DCGI directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the vaccine candidate.

AstraZeneca and the University of Oxford, as the trial sponsor, on Saturday said that they cannot disclose further medical information but confirmed that independent investigations concluded that the trials were safe to restart.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

10 month baby gets new heart, new life

Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’

Kidnapped for ransom in 1998, 26/11 survivor Gautam Adani faces biggest trial

100 engineering colleges in Karnataka to be ‘adopted’ by corporates by next year: IT Minister Kharge

Siddaramaiah defends BPL ration card cancellation, says only ineligible beneficiaries affected

China announces new policy measures to protect its exports from Trump’s new tariff threat

Renovated Medical Oncology OPD and Chemotherapy Day Care Centre inaugurated at Kasturba Hospital, Manipal

Related Articles More

Mumbai terror accused Rana approaches US Supreme Court to challenge extradition to India

Who will be next Maharashtra CM? Mahayuti, MVA constituents drop different names

PM Modi leaves for home after concluding three-nation visit

Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’

Kerala HC quashes FIR against Goa Guv over remarks on Sabarimala women entry

MUST WATCH

Christmas Cake Fruit Mixing

DK Shivakumar

Rose Cultivation

Geethotsava

Naxal Operation


Latest Additions

Mumbai terror accused Rana approaches US Supreme Court to challenge extradition to India

Who will be next Maharashtra CM? Mahayuti, MVA constituents drop different names

Geethartha Chinthane 101: Understanding of universality eases grief

‘Bengaluru Chalo’ protest demand rejection of Kasturirangan Report

Mangaluru: Cyber frauds posing as TRAI representatives fleece Rs 1.71 crore

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.